Inova Software S.A.S.. (7/1/21). "Press Release: Carlyle Partners with Inova. Growth Equity Transaction to Support Inova’s Ambition to Become the Leading Platform for Life Science Collaborations". Lyon. |
2021-07-01 |
Inova Software S.A.S.. (9/27/18). "Press Release: Inova Software Secures Additional Funding from Its Founders and NextStage AM to Support Its Strong Growth". New York, NY. |
2018-09-27 |
Inpart S.A.S.. (2/29/24). "Press Release: Inpart and Evaluate Announce Strategic Partnership to Optimize Biopharma Dealmaking". Lyon. |
2024-02-29 |
IntegraGen S.A.. (1/9/17). "Press Release: IntegraGen Reports Sharp Increase in Sales during 2016". Évry. |
2017-01-09 |
IntegraGen S.A.. (11/12/18). "Press Release: IntegraGen Announces Collaboration with Google Cloud to Offer Large Scale Genomic Analysis Tools for Clinicians and Medical Researchers". Paris. |
2018-11-12 |
IntegraGen S.A.. (2/3/17). "Press Release: IntegraGen Announces Successful Completion of a € 3.7 Million Capital Increase". Évry. |
2017-02-03 |
IntegraGen S.A.. (3/8/17). "Press Release: Laboratoire Cerba Enters into Licensing Agreement with IntegraGen for the Commercialization of miR-31-3p Tumor Expression Test in France, Benelux, Middle East and Africa". Saint-Ouen l’Aumône & Évry. |
2017-03-08 |
IntegraGen S.A.. (4/21/17). "Press Release: IntegraGen Announces 2016 Annual Results". Évry. |
2017-04-21 |
IntegraGen S.A.. (9/7/17). "Press Release: IntegraGen Announces CE-IVD Marking of miRpredX 31-3p Kit which Predicts Patient Response to anti-EGFR Therapy in RAS Wild-Type Metastatic Colorectal Cancer". Évry. |
2017-09-07 |
Ipsen S.A.. (1/12/18). "Press Release: Ipsen Appoints Richard Paulson Executive Vice-President and Chief Executive Officer of Ipsen North America". Paris. |
2018-01-12 |
Ipsen S.A.. (1/24/20). "Press Release: Ipsen’s Palovarotene Clinical Program in Fibrodysplasia Ossificans Progressiva Reaches Prespecified Interim Analysis Futility Criteria". Paris. |
2020-01-24 |
Ipsen S.A.. (1/31/17). "Press Release: Ipsen to Acquire Primary Care Platform in Italy from Akkadeas Pharma". Paris. |
2017-01-31 |
Ipsen S.A.. (1/9/17). "Press Release: Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals". Paris. |
2017-01-09 |
Ipsen S.A.. (1/9/23). "Press Release: Ipsen to Acquire Albireo Accelerating Growth in Rare Disease with Treatments for Several Pediatric Liver Diseases". Paris & Boston, MA. |
2023-01-09 |
Ipsen S.A.. (11/15/18). "Press Release: European Commission Approves Ipsen’s Cabometyx (cabozantinib) for the Treatment of Hepatocellular Carcinoma in Adults Previously Treated with Sorafenib". Paris. |
2018-11-15 |
Ipsen S.A.. (12/18/19). "Press Release: Ipsen Announces Departure of David Meek as Chief Executive Officer". Paris. |
2019-12-18 |
Ipsen S.A.. (2/13/17). "Press Release: Ipsen to Acquire a Portfolio of Select Consumer Healthcare Products from Sanofi". Paris. |
2017-02-13 |
Ipsen S.A.. (2/23/17). "Press Release: Ipsen Delivers Strong 2016 Results and Expects Further Sales Growth and Margin Enhancement for 2017". Paris. |
2017-02-23 |
Ipsen S.A.. (6/27/22). "Press Release: Ipsen to Acquire Epizyme, Expanding Its Portfolio in Oncology". Paris & Cambridge, MA. |
2022-06-27 |
Ipsen S.A.. (9/25/20). "Press Release: Ipsen Appoints Philippe Lopes-Fernandes as Executive Vice President, Chief Business Officer". Paris. |
2020-09-25 |
Jeito Capital. (1/15/20). "Press Release: Rafaèle Tordjman Launches Jeito Capital, a New Private Equity Company Dedicated to Biotech-biopharmaceuticals, and Announces the Closing of Jeito I at €200 Million". Paris. |
2020-01-15 |
Jeito Capital. (1/26/21). "Press Release: First Year-in-Review – Jeito Capital Confirms Strength of Its Investment Model and 2021 Ambitions with more Deals and Significant Capital". Paris. |
2021-01-26 |
Jeito Capital. (11/13/20). "Press Release: Sanofi Selects Jeito Capital as Its First Investment into a Private French-based Fund". Paris. |
2020-11-13 |
Jeito Capital. (12/14/20). "Press Release: Jeito Capital Leads €20 Million Investment in InnoSkel, a New Gene Therapy Company and Leader in Rare Skeletal Disorders". Paris. |
2020-12-14 |
Jeito Capital. (2/17/22). "Press Release: Jeito Capital Announces the Appointments of Dr Andreas Wallnöfer as Partner Investor and Isabelle Meyrier as Head of Legal". Paris. |
2022-02-17 |
Jeito Capital. (2/22/22). "Press Release: Jeito Capital Co-leads $65 Million Series A Financing in EyeBio". Paris. |
2022-02-22 |
Jeito Capital. (5/27/21). "Press Release: Jeito Capital Leads Oversubscribed $92 million Series C Financing Round in Pulmocide". Paris. |
2021-05-27 |
Jeito Capital. (6/15/21). "Press Release: Jeito Capital Becomes Key Investor in Alentis Therapeutics as Part of $67 Million Series B Financing Round". Paris. |
2021-06-15 |
Jeito Capital. (7/28/21). "Press Release: Jeito Capital’s Dr. Rafaèle Tordjman Appointed to Promote the French Biotech Ecosystem". Paris. |
2021-07-28 |
Jeito Capital. (9/20/21). "Press Release: Jeito Capital Becomes Key Player in the Financing of Life Sciences in Europe with the Closing of Jeito I at €534 million ($630 million)". Paris. |
2021-09-20 |
Keensight Capital. (7/23/19). "Press Release: Keensight Capital Acquires 3P Biopharmaceuticals to Accelerate Its Global Growth Strategy". Paris. |
2019-07-23 |
Keranova S.A.. (9/10/19). "Press Release: Keranova Raises €24m in Second Round of Financing". Saint-Etienne & Lyon. |
2019-09-10 |
Kurma Partners. (11/9/20). "Press Release: Kurma Partners Strengthens Its Teams and Promotes Its Talents". Paris. |
2020-11-09 |
Kurma Partners. (12/14/18). "Press Release: Kurma Partners Announces the First Closing of Kurma Biofund III". Paris. |
2018-12-14 |
Kurma Partners. (3/7/22). "Press Release: Kurma Partners Targets €250 Million for its First Growth Opportunities Fund". Paris. |
2022-03-07 |
Kurma Partners. (4/13/21). "Press Release: Jean-François Rivassou Joins Kurma Partners as Partner". Paris. |
2021-04-13 |
Kurma Partners. (4/29/20). "Press Release: Kurma Partners Announces the Final Closing of Its Kurma Biofund III Fund at €160 Million". Paris. |
2020-04-29 |
Kurma Partners. (9/29/20). "Press Release: Kurma Partners Announces the First Closing of Kurma Diagnostics 2 (KDx2) Fund at €50 Million". Paris. |
2020-09-29 |
Lauxera Capital Partners. (9/12/23). "Press Release: Lauxera Capital Partners Invests €17 Million in Swedish Regenerative Medicine Leader BioLamina AB". Paris & San Francisco, CA. |
2023-09-12 |
Leman Instruments SAS. (6/9/17). "Press Release: Leman Instruments Introduces New Family of High Purity Oxygen Generators. OXYSTATION 20 LC and OXYSTATION 40LC Instruments Now Available". Archamps. |
2017-06-09 |
Lesaffre & Cie.. (9/7/22). "Press Release: Lesaffre Acquires Recombia Biosciences, a Biotechnology Company Specialized in High-throughput Genome Editing and Synthetic Biology". Paris & San Francisco, CA. |
2022-09-07 |
Leti. (11/30/17). "Press Release: Leti Develops Meg Technology To Improve Diagnosis Of Epilepsy and Guide Surgeons During Brain Surgery". |
2017-11-30 |
Leti. (12/4/17). "Press Release: Leti Researcher Reappointed Head of the European Technology Platform for Nanomedicine". |
2017-12-04 |
Leti. (12/6/17). "Press Release: Innovation in the Diagnosis of Breast Cancer". |
2017-12-06 |
LimFlow S.A.. (11/1/23). "Press Release: LimFlow Announces Agreement to Be Acquired by Inari Medical". Paris & San José, CA. |
2023-11-01 |
LimFlow S.A.. (4/6/22). "Press Release: LimFlow Raises $40 Million (€36 Million) in Series D Financing". Paris. |
2022-04-06 |
LNC Therapeutics. (4/15/20). "Press Release: LNC Therapeutics Announces the Acquisition of an Exclusive Worldwide Licence on the First Patent related to Christensenella’s Therapeutic Applications in Mood Disorders". Bordeaux. |
2020-04-15 |
LNC Therapeutics. (4/17/18). "Press Release: LNC Therapeutics Appoints New CEO, Dr. Georges Rawadi, and Accelerates Development in Microbiome Research". Bordeaux. |
2018-04-17 |
LNC Therapeutics. (9/27/17). "Press Release: LNC Therapeutics Raises € 6.5 Million and Reinforces Its R&D in the Microbiota Field". Bordeaux. |
2017-09-27 |
LNC Therapeutics. (9/5/19). "Press Release: LNC Therapeutics Raises €6.2 Million for the Clinical Development of New Generation Drugs Based on the Gut Genome". |
2019-09-05 |
LXRepair S.A.S.. (1/20/21). "Press Release: Stéphane Altaba Is Appointed CEO of the Start-up Company LXRepair". Paris. |
2021-01-20 |
Lys Therapeutics S.A.S.. (11/14/22). "Press Release: Lys Therapeutics Announces a Seed Round of 5.5 Million Euros to Prepare Future Clinical Studies for Its First-in-class Monoclonal Antibody targeting neurovascular and neurodegenerative disorders". Lyon |
2022-11-14 |
Lys Therapeutics S.A.S.. (3/15/23). "Press Release: Lys Therapeutics Secures Funding from The Michael J. Fox Foundation to Accelerate the Development of Its Drug Candidate in Parkinson’s Disease". Lyon & Caen. |
2023-03-15 |
Lysogene S.A.. (1/18/17). "Press Release: Lysogene Receives Rare Pediatric Disease Designation from FDA for LYS-GM101 for Treatment of GM1 Gangliosidosis". Paris & Cambridge, MA. |
2017-01-18 |
Lysogene S.A.. (1/25/17). "Press Release: Lysogene Launches Its IPO on Euronext’s Regulated Market in Paris". |
2017-01-25 |
Lysogene S.A.. (10/17/19). "Press Release: Lysogene Appoints Mr. Stéphane Durant des Aulnois as Chief Financial Officer". Paris. |
2019-10-17 |
Lysogene S.A.. (2/2/17). "Press Release: Lysogene Receives Orphan Drug Designation from FDA for LYS-GM101 for Treatment of GM1 Gangliosidosis". Paris. |
2017-02-02 |
Lysogene S.A.. (2/21/17). "Press Release: Lysogene Receives Orphan Drug Designation from EMA for LYS-GM101 for Treatment of GM1 Gangliosidosis". Paris & Cambridge, MA. |
2017-02-21 |
Lysogene S.A.. (2/7/17). "Press Release: Lysogene Announces Its Successful IPO on Euronext Paris with nearly €22.6m Raised [Not for US, CA, AU, JP]". Paris. |
2017-02-07 |
Lysogene S.A.. (3/12/20). "Press Release: Lysogene Completes €7.7 Million Capital Increase in a Placement Led by Leading Healthcare Investor OrbiMed and Lysogene Shareholder and Partner Sarepta [Not for US, CA, AU or JP]". Paris. |
2020-03-12 |
Lysogene S.A.. (4/20/17). "Press Release: Lysogene Announces Selection of MRI Interventions’ SmartFlow Cannula for Phase II/III Clinical Study in MPS IIIA". Paris & Cambridge, MA. |
2017-04-20 |
Lysogene S.A.. (4/21/17). "Press Release: 2016 Annual Results". Paris & Cambridge, MA. |
2017-04-21 |
Lysogene S.A.. (7/1/20). "Press Release: Lysogene Announces a Research Collaboration with the Weizmann Institute of Science". Paris. |
2020-07-01 |
L’Oréal S.A.. (12/5/18). "Press Release: L'Oréal Creates a Corporate Venture Capital Fund Dedicated to Accompanying Innovative Startups". Clichy. |
2018-12-05 |
MaaT Pharma. (10/15/21). "Press Release: MaaT Pharma Launches Its Initial Public Offering on the Regulated Market of Euronext in Paris [ Not for US, CA, AU, JP or RK ]". Lyon. |
2021-10-15 |
MaaT Pharma. (12/1/20). "Press Release: MaaT Pharma Announces Series B Extension and Final Closing with Total of €25 Million ($29.5 Million)". Lyon. |
2020-12-01 |
MaaT Pharma. (2/5/20). "Press Release: MaaT Pharma Announces €18 Million Series B Financing Round to Support Further Clinical Development of Microbiome Biotherapeutics". Lyon. |
2020-02-05 |
MaaT Pharma. (5/28/20). "Press Release: MaaT Pharma Appoints Savita Bernal as Chief Business Officer". Lyon. |
2020-05-28 |
MaaT Pharma. (6/21/23). "Press Release: MaaT Pharma Announces New Appointments to the Board and Executive Team". Lyon. |
2023-06-21 |
Mablink Bioscience S.A.S.. (10/14/22). "Press Release: Mablink Bioscience Announces a €31 Million Series A Funding Round Led by Sofinnova Partners and Mérieux Equity Partners". Lyon. |
2022-10-14 |
Mablink Bioscience S.A.S.. (10/18/23). "Press Release: Mablink Bioscience Enters an Agreement to be Acquired by Lilly". Lyon. |
2023-10-18 |
Mablink Bioscience S.A.S.. (10/21/21). "Press Release: Mablink Bioscience and Emergence Therapeutics Enter into a Licensing Agreement to Develop Antibody Drug Conjugate as a Potential Cancer Therapy". Lyon & Duisburg. |
2021-10-21 |
Mablink Bioscience S.A.S.. (4/27/21). "Press Release: Mablink Bioscience, the Next Generation ADC Company, Raises €4 Million from a Syndicate of Private Investors". Lyon. |
2021-04-27 |
Magnisense SE. (10/24/18). "Press Release: Magnisense Successfully Raises € 5 Nillion to Boost the Commercial Development of Its MiAG Emergency Diagnostic Tests for Heart Diseases". Paris. |
2018-10-24 |
McDermott Will & Emery. (1/6/17). "Press Release: McDermott Will & Emery Advised Servier in Its License Option Agreement with OSE Immunotherapeutics". Paris. |
2017-01-06 |
McDermott Will & Emery. (1/9/17). "Press Release: McDermott Will & Emery Advised Servier in Its Strategic Immuno-oncology Co-development Alliance with Pieris Pharmaceuticals". Paris. |
2017-01-09 |
MedDay Pharmaceuticals S.A.S.. (3/10/20). "Press Release: MedDay Reports Top-line Data from Phase III Trial »SPI2« for Treatment of Progressive Forms of Multiple Sclerosis". Paris. |
2020-03-10 |
Median Technologies S.A.. (12/14/23). "Press Release: Median Technologies and PASREL-Imagerie Join Forces to Deliver Smart Imaging Biomarkers Supporting the Development of New Oncology Drugs in Precision Medicine". Sophia Antipolis & Saclay. |
2023-12-14 |
Medicen Paris Region. (4/20/20). "Press Release: Medicen Paris Region Appoints Jessica Leygues as CEO". Paris. |
2020-04-20 |
Medicen Paris Region. (5/23/17). "Press Release: French Tech Tour Healthcare Israel. Seven Start-ups Assess their Business Potential with Business France, Bpifrance and Medicen Paris Region". Paris. |
2017-05-23 |
Medicen Paris Region. (6/14/18). "Press Release: Medicen Paris Region Appoints Stéphane Roques as CEO". Paris. |
2018-06-14 |
Medicen Paris Region. (9/7/17). "Press Release: BioWin and Medicen Focus on Developing Medical Imaging and Digital Health in Europe". Gosselies & Paris. |
2017-09-07 |
Medigene AG. (4/28/17). "Press Release: Medigene Announces Participation at Six International Conferences". Planegg. |
2017-04-28 |
MedinCell S.A.. (11/28/19). "Press Release: MedinCell Receives $19 Million Grant for Its mdc-WWM Program". Montpellier. |
2019-11-28 |
MedinCell S.A.. (11/30/22). "Press Release: Additional US$ 4 Million Received for Next Development Steps of MedinCell’s 6-month Active Injectable Bioresorbable Subcutaneous Contraceptive". Montpellier. |
2022-11-30 |
MedinCell S.A.. (2/11/21). "Press Release: Tremendous Success for MedinCell’s €30 Million Capital Increase for Qualified Investors". Montpellier. |
2021-02-11 |
MedinCell S.A.. (3/25/20). "Press Release: MedinCell Receives $ 6.4 Million Grant from Unitaid to Fight Malaria". Montpellier. |
2020-03-25 |
MedinCell S.A.. (5/27/20). "Press Release: MedinCell Secures €10.9 Million Non-Dilutive Financing". Montpellier. |
2020-05-27 |
MedinCell S.A.. (6/16/20). "Press Release: MedinCell Announces the Great Success of Its Capital Increase and Raises 15.6 M€ [Not for publication nor to distribution in the United States, Canada, Japan or Australia]". Montpellier. |
2020-06-16 |
Meiogenix S.A.S.. (12/14/21). "Press Release: Meiogenix Announces $13 Million Series A Financing Round Led by Sofinnova Partners". Paris. |
2021-12-14 |
Meletios Therapeutics S.A.S.. (2/28/22). "Press Release: Meletios Therapeutics Signs an Exclusive License Agreement with the Institut Pasteur for the Development of a New Class of Antivirals". Paris. |
2022-02-28 |
Meletios Therapeutics S.A.S.. (8/30/21). "Press Release: Meletios Therapeutics Raises €3.8 Million for the Development of a New Generation of Antiviral Treatments". Paris. |
2021-08-30 |
Mérieux Equity Partners S.A.S.. (1/8/20). "Press Release: Mérieux Equity Partners Successfully Completes the Fundraising of Mérieux Participations 3". Lyon. |
2020-01-08 |
Mérieux Equity Partners S.A.S.. (12/8/20). "Press Release: Cell-Easy Announces the Completion of a Financing Round to Accelerate Its Growth Trajectory in the Cell Therapy Sector, With Merieux Equity Partners as Lead Investor and Reference Shareholder". T |
2020-12-08 |
Metafora Biosystems S.A.S.. (6/11/18). "Press Release: Metafora Biosystems Receives €3.2 Million from European Commission’s H2020 SME Instrument Program". Paris. |
2018-06-11 |
Micropep Technologies S.A.S.. (3/6/18). "Press Release: Micropep Technologies Completes a €4M Seed Round to Boost the Development of Its Unique Discovery Engine". Toulouse. |
2018-03-06 |
Micropep Technologies S.A.S.. (6/27/22). "Press Release: Micropep, Ag-Biotech innovator, Raises €8.75 Million from Global Syndicate to Bring Ground-breaking and Cost-effective Alternatives to Conventional Crop Protection Products to Market". Toulouse. |
2022-06-27 |
Micropep Technologies S.A.S.. (7/8/21). "Press Release: Micropep Raises EUR 8.5M (USD 10M) in Oversubscribed Series A Financing to Develop Innovative Small Peptide Solutions for Agriculture". Toulouse. |
2021-07-08 |
Microphyt S.A.. (7/30/18). "Press Release: Microphyt Is Strengthening Its Teams to Accelerate the Commercialization of Its Natural Active Ingredients Derived from Microalgae". |
2018-07-30 |
Microphyt. (7/11/19). "Press Release: Microphyt Raises €28.5 Million to Develop Its Portfolio of Microalgae-based Natural Solutions for Nutrition and Well-being". Baillargues. |
2019-07-11 |